TM
OKUR

Torren Management’s OnKure Therapeutics OKUR Stock Holding History

Torren Management’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-504
Closed -$1.46K – 1467
2025
Q4 		$1.46K Buy
+504
New +$1.51K ﹤0.01% 1129

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Torren Management's OKUR Position: Q1 2026 in Review

Torren Management sold out of OnKure Therapeutics (OKUR) in Q1 2026, closing a stake of 504 shares — an estimated $1.46K sold.

Torren Management first reported a position in OKUR in Q4 2025 and held it in 1 quarter. The position peaked at $1.46K in Q4 2025. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Torren Management reported no remaining OnKure Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Torren Management sold 504 OnKure Therapeutics shares in Q1 2026, an estimated $1.46K.
  • Torren Management first reported a position in OnKure Therapeutics in Q4 2025 and held it in 1 quarter.
  • Torren Management's OnKure Therapeutics position peaked at $1.46K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.